Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liingo Eyewear was a U.S.-based direct-to-consumer eyewear company focused on selling prescription glasses online, including a free in-home try-on program and prescription lenses bundled with frames. The company operated at the intersection of consumer vision care, digital retail, and tele-optical services rather than drug development or biotechnology. Liingo was founded in 2016 in Draper, Utah and was acquired by 1-800 Contacts at the end of 2017, with the acquisition announced in January 2018. After operating within the 1-800 Contacts organization for several years, the Liingo brand was rebranded as The Framery in 2025. For a biotech analyst, this is best categorized as a commercial vision-care retail and digital eyewear brand, not a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liingo Eyewear.